β-Cell Dysfunction in COVID-19 and Post-COVID Syndrome: Molecular Mechanisms Linking Inflammation, Oxidative Stress, and Insulin Secretion
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27167083 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Victoria Tsvetkova und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Pulmonology and Endocrinology, Medical University, 5800 Pleven, Bulgaria. Hauptthemen laut MEDLINE: Oxidative Stress, COVID-19, Insulin-Secreting Cells, Inflammation. Die Arbeit nennt 180 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Coronavirus disease 2019 (COVID-19) is increasingly recognized as a multisystem disorder associated with persistent metabolic complications extending beyond the acute phase of infection. Accumulating evidence suggests that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may disrupt glucose homeostasis through mechanisms involving pancreatic β-cell dysfunction, insulin resistance, chronic inflammation, oxidative stress, mitochondrial dysfunction, and hypoxia-related signalling. This review summarizes current evidence regarding the molecular and cellular mechanisms linking SARS-CoV-2 infection to impaired insulin secretion and post-COVID metabolic disturbances. Particular emphasis is placed on the regulation of insulin secretion, β-cell compensation and failure, oxidative stress, inflammatory signalling, mitochondrial dysfunction, and the development of the post-COVID metabolic phenotype. Emerging evidence indicates that persistent metabolic abnormalities after COVID-19 may range from transient dysglycaemia to new-onset diabetes mellitus and metabolic syndrome. The review also discusses clinical implications, biomarkers, therapeutic perspectives, and unresolved questions regarding the reversibility of post-COVID β-cell dysfunction. A better understanding of the mechanisms underlying post-COVID metabolic dysfunction may improve risk stratification, facilitate early intervention, and support development of targeted therapeutic strategies aimed at preserving β-cell function and long-term metabolic health.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Pulmonology and Endocrinology, Medical University, 5800 Pleven, Bulgaria.
- Clinic of Endocrinology and Metabolic Disease, University Hospital Georgi Stranski, 5800 Pleven, Bulgaria.
ORCID-Profile: Victoria Tsvetkova, Katya Todorova
Zitieren
APA
Tsvetkova, V., & Todorova, K. (2026). β-Cell Dysfunction in COVID-19 and Post-COVID Syndrome: Molecular Mechanisms Linking Inflammation, Oxidative Stress, and Insulin Secretion. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27167083
Vancouver
Tsvetkova V, Todorova K. β-Cell Dysfunction in COVID-19 and Post-COVID Syndrome: Molecular Mechanisms Linking Inflammation, Oxidative Stress, and Insulin Secretion. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27167083
BibTeX
@article{Tsvetkova2026,
author = {Tsvetkova, Victoria and Todorova, Katya},
title = {β-Cell Dysfunction in COVID-19 and Post-COVID Syndrome: Molecular Mechanisms Linking Inflammation, Oxidative Stress, and Insulin Secretion},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27167083}
}
EUVIMED